Log in to save to my catalogue

Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [18F]fluo...

Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [18F]fluo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c889333eed8045fbbd7ee7a3be611495

Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [18F]fluortriopride

About this item

Full title

Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [18F]fluortriopride

Publisher

Cham: Springer International Publishing

Journal title

EJNMMI Physics, 2018-10, Vol.5 (1), p.21-12, Article 21

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Background
[
18
F]Fluortriopride (FTP) was developed as a dopamine D3-selective radiotracer, thought to be important to neurobiological reward pathways and implicated in drug addiction, Parkinson’s disease, and schizophrenia. Preclinical radiation dosimetry studies found the gallbladder wall received the highest dose. A gallbladder dose re...

Alternative Titles

Full title

Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [18F]fluortriopride

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c889333eed8045fbbd7ee7a3be611495

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c889333eed8045fbbd7ee7a3be611495

Other Identifiers

ISSN

2197-7364

E-ISSN

2197-7364

DOI

10.1186/s40658-018-0219-6

How to access this item